Osteoarthritis Analgesic Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new report on the osteoarthritis analgesic market. This study includes the statistical and analytical approaches needed to grow the osteoarthritis analgesic market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-104352

The global osteoarthritis analgesic market is expected to grow at a CAGR of 7.9% during the 2019-2025 forecast period.

Osteoarthritis is growing as a major public health problem around the world. The rapidly growing aging population is a major factor in the increasing number of people suffering from osteoarthritis. The World Health Organization (WHO) reports that osteoarthritis is more common in women over the age of 60 than in men. This will increase the demand for painkillers for osteoarthritis. In addition, rising R & D spending and the growing aging population are other factors driving the growth of the osteoarthritis analgesic market. Increasing awareness of degenerative bone disease in developing countries and a rich pipeline of innovative treatment options are also expected to drive market growth.

However, the serious side effects associated with certain injectable treatments are a major limiting factor to market growth.

Market segment
The painkiller market for osteoarthritis of the art is by drug class (corticosteroids, NSAIDS, mucus replacement, etc.), route of administration (oral, parenteral, topical), and distribution channel (hospital pharmacies, retail pharmacies, online). It is divided by pharmacy) and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL
https://www.sdki.jp/sample-request-104352

Area overview
The North American region holds a dominant share of the osteoarthritis analgesic market. The availability of better treatment options, high awareness among people, and government reimbursement policies are key factors driving market growth in the region. Meanwhile, the Asia-Pacific region holds the second largest market share in the osteoarthritis analgesic market. China's retirement support rate is projected to plummet from 7.9 to 2.4 by 2050, driving demand for osteoarthritis analgesics in the Asia-Pacific region.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific); Latin America (Brazil, Mexico, Argentina, and other Latin). USA); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy, Spain) , Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Details of the survey report
https://www.sdki.jp/reports/osteoarthritis-pain-drug-market/104352

Key Players on the Market The key players on the
osteoarthritis analgesics market are:
Horizon Pharma plc
Pfizer Inc
Sanofi SA
Anika Therapeutics, Inc.
Ferring BV
Bioventus, Inc.
Chugai Pharmaceutical Co., Limited
Alkem Laboratories
Flexion Therapeutics, Inc.
Zimmer Biomet Holdings, Inc.
The study includes a detailed competitive analysis, corporate profile, recent developments, and key market strategies for these leading companies in the osteoarthritis analgesic market.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.